Traditional Therapy Clinics Limited (ASX:TTC) has entered into contracts to acquire four clinics from its franchised clinic base in line with its business strategy to grow its owned clinic network and diversify its revenue stream.

Compumedics Limited (ASX:CMP) is a leading global, innovative developer and manufacturer of medical devices.

Compumedics Limited (ASX:CMP) is pleased to announce the release of an initiating research report by PAC partners.

Compumedics Limited (ASX:CMP) is pleased to announce that it has secured a new three-year contract for the distribution of Compumedics' sleep diagnostic and monitoring systems across provinces in and around Shanghai with one of its long-term distribution partners in China, ZhiNuo.

Compumedics Limited (ASX:CMP) ("Compumedics" and "Company") is pleased to announce that it has secured a new three-year contract, for the distribution of Compumedics' Neuroscan Brain Research and neurology systems in South Korea with the Company's long-term distribution partner, Kwangwon.

Compumedics Limited (ASX:CMP) is pleased to announce that it has secured a $600,000 order to fit out the neurology department at the new Perth Children's Hospital, which is currently under construction.

Leading Australia-based medical device company, Compumedics Limited (ASX:CMP), is pleased to announce revenue and earnings growth for the year ending 30 June 2015. Comparable shipped and invoiced sales were $33.5m compared to $30.8m in the previous year.

Compumedics Limited (ASX:CMP) Preliminary 30 June 2015 Guidance

Compumedics Limited (ASX:CMP) is pleased to announce that the Company's Germany-based brain blood-flow Doppler ultrasonography division, Compumedics Germany GmbH (or DWL), has secured a tranche of deals totalling AU$5 million (Euro 3.7 million) over 3 years to supply its TCD systems to the German market.

Compumedics Limited (ASX:CMP) is pleased to announce that it has secured a new three-year contract, for the distribution of Compumedics' sleep diagnostic and monitoring systems across provinces in North, West and Central China with its long-term distribution partner and shareholder, Beijing Bestmed.